Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$2.04M Buy
37,352
+27,480
+278% +$1.3M 0.01% 799
2019
Q3
$368K Sell
9,872
-20,300
-67% -$789K ﹤0.01% 1835
2019
Q2
$1.13M Buy
30,172
+18,328
+155% +$576K 0.01% 1056
2019
Q1
$353K Sell
11,844
-11,264
-49% -$396K ﹤0.01% 1842
2018
Q4
$692K Buy
23,108
+888
+4% +$28.2K 0.01% 1186
2018
Q3
$795K Sell
22,220
-596
-3% -$18.5K 0.01% 1135
2018
Q2
$542K Buy
22,816
+21,940
+2,505% +$465K 0.01% 1246
2018
Q1
$16K Sell
876
-872
-50% -$12.9K ﹤0.01% 3813
2017
Q4
$24K Sell
1,748
-1,680
-49% -$21.8K ﹤0.01% 3590
2017
Q3
$42K Sell
3,428
-3,112
-48% -$55K ﹤0.01% 3061
2017
Q2
$120K Buy
6,540
+3,348
+105% +$61.8K ﹤0.01% 2160
2017
Q1
$67K Buy
3,192
+128
+4% +$2.5K ﹤0.01% 2475
2016
Q4
$46K Sell
3,064
-512
-14% -$9.07K ﹤0.01% 2668
2016
Q3
$78K Buy
3,576
+324
+10% +$7.21K ﹤0.01% 2178
2016
Q2
$62K Buy
+3,252
New +$55.4K ﹤0.01% 2254

Other funds holding DXCM

Advisor Group's DXCM Position: Q4 2019 in Review

Advisor Group increased its DexCom (DXCM) stake by 278% in Q4 2019, buying an estimated $1.3M and bringing the position to 37,352 shares worth $2.04M. The position accounts for 0.01% of the portfolio, ranked #799.

Advisor Group first reported a position in DXCM in Q2 2016 and has held it in 15 quarters since. 508 funds tracked by Wall St. Rank hold DXCM as of Q4 2019.

  • Advisor Group held 37,352 shares of DexCom worth $2.04M as of Q4 2019.
  • Advisor Group bought 27,480 DexCom shares in Q4 2019, an estimated $1.3M.
  • DexCom made up 0.01% of Advisor Group's portfolio in Q4 2019, its #799 holding.
  • Advisor Group first reported a position in DexCom in Q2 2016 and has held it in 15 quarters since.
  • 508 funds tracked by Wall St. Rank held DexCom as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.